Galapagos Genomics NV And BASF AG Extend Research Collaborations
Drug discovery company, Galapagos NV said it has extended three research collaborations into 2006 with BASF Aktiengesellschaft in Ludwigshafen, Germany with the total contract value of the extensions exceeding 700,000 eur.